Literature DB >> 7729631

Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease.

Y Liu1, H J van Kruiningen, A B West, R W Cartun, A Cortot, J F Colombel.   

Abstract

BACKGROUND/AIMS: Infectious agents have long been suspected of playing a role in the initiation of Crohn's disease. The objective of this study was to search for likely microbial agents in diseased tissues using immunocytochemical techniques.
METHODS: Intestines and mesenteric lymph node specimens of 21 patients from two French families with a high frequency of Crohn's disease and from Connecticut were studied. The microbial agents searched for included Bacteroides vulgatus, Borrelia burgdorferi, Escherichia coli, Listeria monocytogenes, Streptococcus spp., bovine viral diarrhea virus, influenza A virus, measles virus, parainfluenza virus, and respiratory syncytial virus.
RESULTS: Seventy-five percent of the patients with Crohn's disease (12 of 16) were positively labeled with the antibody to Listeria. Macrophages and giant cells immunolabeled for this antigen were distributed underneath ulcers, along fissures, around abscesses, within the lamina propria, in granulomas, and in the germinal centers of mesenteric lymph nodes. In addition, 57% (12 of 21) of the cases contained the E. coli antigen, and 44% (7 of 16) contained the streptococcal antigen. The immunolabeling for the latter two agents also occurred within macrophages and giant cells, distributed in a pattern similar to that of Listeria antigen.
CONCLUSIONS: The results suggest that Listeria spp., E. coli, and streptococci, but not measles virus, play a role in the pathogenesis of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729631      PMCID: PMC7127655          DOI: 10.1016/0016-5085(95)90687-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  35 in total

1.  Mycobacterium paratuberculosis DNA in Crohn's disease tissue.

Authors:  J D Sanderson; M T Moss; M L Tizard; J Hermon-Taylor
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Listeria isolations from feces of patients with diarrhea and from healthy food handlers.

Authors:  H E Müller
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

3.  Escherichia coli antibodies in patients with inflammatory bowel disease.

Authors:  S Tabaqchali; D P O'Donoghue; K A Bettelheim
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

4.  Radioimmunologic measurements of naturally occurring bacterial antibodies. I. Human serum antibodies reactive with Escherichia coli in gastrointestinal and immunologic disorders.

Authors:  W R Brown; E M Lee
Journal:  J Lab Clin Med       Date:  1973-07

5.  Antibodies against Chlamydia of lymphogranuloma-venereum type in Crohn's disease.

Authors:  J L Schuller; J Piket-van Ulsen; I V Veeken; M F Michel; E Stolz
Journal:  Lancet       Date:  1979-01-06       Impact factor: 79.321

6.  Microbial interference and colonization of the murine gastrointestinal tract by Listeria monocytogenes.

Authors:  Z Zachar; D C Savage
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

7.  Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens.

Authors:  M J Blaser; R A Miller; J Lacher; J W Singleton
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

Review 8.  Histomorphology of experimental listeriosis.

Authors:  B Heymer; C H Wirsing von König; H Finger; H Hof; P Emmerling
Journal:  Infection       Date:  1988       Impact factor: 3.553

9.  Studies of Campylobacter jejuni in patients with inflammatory bowel disease.

Authors:  M J Blaser; D Hoverson; I G Ely; D J Duncan; W L Wang; W R Brown
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

10.  Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments.

Authors:  R B Sartor; W J Cromartie; D W Powell; J H Schwab
Journal:  Gastroenterology       Date:  1985-09       Impact factor: 22.682

View more
  76 in total

1.  Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.

Authors:  C L Sutton; H Yang; Z Li; J I Rotter; S R Targan; J Braun
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

Review 2.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 3.  Detection of persistent measles virus infection in Crohn's disease: current status of experimental work.

Authors:  S Ghosh; E Armitage; D Wilson; P D Minor; M A Afzal
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 4.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

Review 5.  Crohn disease: a current perspective on genetics, autophagy and immunity.

Authors:  Thaddeus S Stappenbeck; John D Rioux; Atsushi Mizoguchi; Tatsuya Saitoh; Alan Huett; Arlette Darfeuille-Michaud; Tom Wileman; Noboru Mizushima; Simon Carding; Shizuo Akira; Miles Parkes; Ramnik J Xavier
Journal:  Autophagy       Date:  2011-04-01       Impact factor: 16.016

Review 6.  Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical.

Authors:  Gary E Wild; Laurie Drozdowski; Carmela Tartaglia; M Tom Clandinin; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

7.  Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli.

Authors:  M M Heimesaat; A Fischer; H-K Jahn; J Niebergall; M Freudenberg; M Blaut; O Liesenfeld; R R Schumann; U B Göbel; S Bereswill
Journal:  Gut       Date:  2007-01-25       Impact factor: 23.059

8.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

9.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.

Authors:  S J Ott; M Musfeldt; D F Wenderoth; J Hampe; O Brant; U R Fölsch; K N Timmis; S Schreiber
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 10.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.